These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10513757)

  • 1. Meta-analysis of diagnostic tests with imperfect reference standards.
    Walter SD; Irwig L; Glasziou PP
    J Clin Epidemiol; 1999 Oct; 52(10):943-51. PubMed ID: 10513757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data.
    Walter SD
    Stat Med; 2002 May; 21(9):1237-56. PubMed ID: 12111876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian meta-analysis of Papanicolaou smear accuracy.
    Cong X; Cox DD; Cantor SB
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S133-7. PubMed ID: 17908587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of Pap test accuracy.
    Fahey MT; Irwig L; Macaskill P
    Am J Epidemiol; 1995 Apr; 141(7):680-9. PubMed ID: 7702044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unification of models for meta-analysis of diagnostic accuracy studies without a gold standard.
    Liu Y; Chen Y; Chu H
    Biometrics; 2015 Jun; 71(2):538-47. PubMed ID: 25358907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded review of papanicolaou smears.
    Frable WJ
    Cancer; 2004 Jun; 102(3):133-5. PubMed ID: 15211470
    [No Abstract]   [Full Text] [Related]  

  • 7. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.
    Nanda K; McCrory DC; Myers ER; Bastian LA; Hasselblad V; Hickey JD; Matchar DB
    Ann Intern Med; 2000 May; 132(10):810-9. PubMed ID: 10819705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the accuracy of Pap smears.
    Evans TC
    Postgrad Med; 1997 Sep; 102(3):63. PubMed ID: 9300017
    [No Abstract]   [Full Text] [Related]  

  • 9. The Pap smear: take two.
    Shulman JJ; Hontz A; Sedlis A; Walters AT; Balin H; LoScuito L
    Am J Obstet Gynecol; 1975 Apr; 121(8):1024-8. PubMed ID: 1119496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors which affect cytodiagnosis in gynecology].
    Kobilková J; Lojda Z; Dusková J; Beková A
    Cesk Patol; 2001 Jan; 37(1):10-4. PubMed ID: 11268699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receiver operating characteristic curves for analysis of the results of cervicovaginal smears. A useful quality improvement tool.
    Renshaw AA; Dean BR; Cibas ES
    Arch Pathol Lab Med; 1997 Sep; 121(9):968-75. PubMed ID: 9302930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases.
    Renshaw AA
    Cancer; 1997 Oct; 81(5):264-71. PubMed ID: 9349512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
    Frable WJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.
    Davey DD
    Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blinded review of Papanicolaou smears.
    Gill GW
    Cancer; 2005 Apr; 105(2):53-5. PubMed ID: 15662699
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the incidence of invasive cervical cancer.
    Helfand M; O'Connor GT; Zimmer-Gembeck M; Beck JR
    Med Care; 1992 Dec; 30(12):1067-82. PubMed ID: 1453813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methodological framework to distinguish spectrum effects from spectrum biases and to assess diagnostic and screening test accuracy for patient populations: application to the Papanicolaou cervical cancer smear test.
    Elie C; Coste J;
    BMC Med Res Methodol; 2008 Feb; 8():7. PubMed ID: 18291032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common problems in Papanicolaou smear interpretation.
    DeMay RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.
    Cárdenas-Turanzas M; Nogueras-Gonzalez GM; Scheurer ME; Adler-Storthz K; Benedet JL; Beck JR; Follen M; Cantor SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2865-71. PubMed ID: 18843032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.